Commentary

Commentary

Let the Obamacare subsidies expire

As members of Congress return to their districts this month, they may receive earfuls about extending the Biden administration‘s enhanced subsidies for Obamacare, which are scheduled to expire at the end of this year. Pundits warn that, unless Congress extends the subsidies, premiums in the individual market could increase by ...
Commentary

Drugmakers Are Embracing Direct-To-Consumer Sales. That’s Fantastic News For Patients.

Several Big Pharma companies have started selling their drugs directly to consumers (DTC). This shift — driven in part by President Trump’s push for lower drug prices and fewer middlemen — has garnered relatively little media coverage. But the implications for American patients, employers, and the healthcare system as a ...
Commentary

Obscuring the forest for the trees: Most LAUSD students still below standards

Recently, Los Angeles school superintendent Alberto Carvalho held a celebratory press conference to trumpet the incremental increase in the district’s student test scores, but while he was focusing on some bright trees, the dark forest remains—a large majority of Los Angeles students still fail to meet state grade-level standards in ...
Commentary

Obamacare Premiums Are Climbing Again. But Americans Finally Have An Alternative

Get ready to pay more for insurance coverage through Obamacare’s exchanges. The median premium increase for plans from 105 insurers in 19 states and the District of Columbia will be 15% in 2026, according to the Kaiser Family Foundation. That’s more than double the median premium increase of 7% this ...
Commentary

Drug Tariffs Cure Nothing and Are a Tax Increase

President Donald Trump has made no secret of his desire for sweeping tariffs on pharmaceuticals. Last month, the president threatened tariffs as high as 200% on imported drugs. The trade deal with the European Union (EU) finalized July 27 includes a 15% levy on medicines imported from the continent. Drug ...
Commentary

We don’t need socialism to cut drug prices. Americans get a good deal

Nearly nine in every 10 Americans say that prescription drug prices are too high. Yet the average prescription costs less in the U.S. than in other developed countries, according to a new study from professor Tomas Phillipson, the former chairman of the White House Council of Economic Advisers. That finding ...
California

Advice from California: Pay attention to what Newsom does, not what he says

California Gov. Gavin Newsom recently barnstormed South Carolina on a two-day, presidential campaign-style tour, touting what he calls “the California Way.” Light on specifics and heavy on partisan red meat, Newsom told Palmetto State audiences that the California he leads is “the most un-Trump state.” When challenged to a debate ...
California

Goodbye Golden State: In-N-Out Burger says enough to California’s crushing business climate

California already has lost a number of its legacy companies to more business-friendly states, but when the owner of an iconic burger chain leaves for Tennessee, where she will take a chunk of employees and set up a second company headquarters, the sting has to hurt a little more. Lynsi ...
Commentary

Medicaid At 60: A Safety Net In Need Of Serious Repair

Today, Medicaid turns 60. But this will be no diamond jubilee. What began in 1965 as a modest safety-net program has ballooned into the largest health entitlement in the country, covering nearly 80 million Americans, costing close to $900 billion a year, and delivering poor value for both patients and ...
Commentary

Doctors Deserve More Than a Token Pay ‘Raise’ from Medicare

The Trump administration is giving doctors a modest pay raise. A proposal released this month by the Centers for Medicare and Medicaid Services would, among other things, implement the 2.5% hike in Medicare physician reimbursement established by the One Big Beautiful Bill Act, which President Trump signed into law July ...
Commentary

Let the Obamacare subsidies expire

As members of Congress return to their districts this month, they may receive earfuls about extending the Biden administration‘s enhanced subsidies for Obamacare, which are scheduled to expire at the end of this year. Pundits warn that, unless Congress extends the subsidies, premiums in the individual market could increase by ...
Commentary

Drugmakers Are Embracing Direct-To-Consumer Sales. That’s Fantastic News For Patients.

Several Big Pharma companies have started selling their drugs directly to consumers (DTC). This shift — driven in part by President Trump’s push for lower drug prices and fewer middlemen — has garnered relatively little media coverage. But the implications for American patients, employers, and the healthcare system as a ...
Commentary

Obscuring the forest for the trees: Most LAUSD students still below standards

Recently, Los Angeles school superintendent Alberto Carvalho held a celebratory press conference to trumpet the incremental increase in the district’s student test scores, but while he was focusing on some bright trees, the dark forest remains—a large majority of Los Angeles students still fail to meet state grade-level standards in ...
Commentary

Obamacare Premiums Are Climbing Again. But Americans Finally Have An Alternative

Get ready to pay more for insurance coverage through Obamacare’s exchanges. The median premium increase for plans from 105 insurers in 19 states and the District of Columbia will be 15% in 2026, according to the Kaiser Family Foundation. That’s more than double the median premium increase of 7% this ...
Commentary

Drug Tariffs Cure Nothing and Are a Tax Increase

President Donald Trump has made no secret of his desire for sweeping tariffs on pharmaceuticals. Last month, the president threatened tariffs as high as 200% on imported drugs. The trade deal with the European Union (EU) finalized July 27 includes a 15% levy on medicines imported from the continent. Drug ...
Commentary

We don’t need socialism to cut drug prices. Americans get a good deal

Nearly nine in every 10 Americans say that prescription drug prices are too high. Yet the average prescription costs less in the U.S. than in other developed countries, according to a new study from professor Tomas Phillipson, the former chairman of the White House Council of Economic Advisers. That finding ...
California

Advice from California: Pay attention to what Newsom does, not what he says

California Gov. Gavin Newsom recently barnstormed South Carolina on a two-day, presidential campaign-style tour, touting what he calls “the California Way.” Light on specifics and heavy on partisan red meat, Newsom told Palmetto State audiences that the California he leads is “the most un-Trump state.” When challenged to a debate ...
California

Goodbye Golden State: In-N-Out Burger says enough to California’s crushing business climate

California already has lost a number of its legacy companies to more business-friendly states, but when the owner of an iconic burger chain leaves for Tennessee, where she will take a chunk of employees and set up a second company headquarters, the sting has to hurt a little more. Lynsi ...
Commentary

Medicaid At 60: A Safety Net In Need Of Serious Repair

Today, Medicaid turns 60. But this will be no diamond jubilee. What began in 1965 as a modest safety-net program has ballooned into the largest health entitlement in the country, covering nearly 80 million Americans, costing close to $900 billion a year, and delivering poor value for both patients and ...
Commentary

Doctors Deserve More Than a Token Pay ‘Raise’ from Medicare

The Trump administration is giving doctors a modest pay raise. A proposal released this month by the Centers for Medicare and Medicaid Services would, among other things, implement the 2.5% hike in Medicare physician reimbursement established by the One Big Beautiful Bill Act, which President Trump signed into law July ...
Scroll to Top